The value added by government venture capital funds compared with independent venture capital funds
By Terttu Luukkonen, Matthias Deschryvere, F. Bertoni. 2013
128 citations recorded by the source corpus.
Subfields: Accounting, Economics and Econometrics
View Paper: https://www.semanticscholar.org/paper/12be9cb6d3256d8366e7d9330d95ae40ac372434
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Accounting
- F. Bertoni
- A. Quas
- Massimo G. Colombo
- Tereza Tykvová
- Luca Grilli
- Massimiliano Guerini
- Samuele Murtinu
- M. Vivarelli
In Economics and Econometrics
- F. Bertoni
- A. Quas
- Massimo G. Colombo
- Tereza Tykvová
- Luca Grilli
- Massimiliano Guerini
- Samuele Murtinu
- M. Vivarelli
Citations in the corpus
- Patents, Trademarks, and Their Complementarity in Venture Capital Funding (2016, unknown): “VC is an important source of funding for innovative start-ups (Luukkonen et al., 2013; Pandey and Jang, 1996).”
- The patterns of venture capital investment in Europe (2015, background): “…et al. 2008; Schwienbacher 2008; Schwienbacher et al. 2009; Alperovych and Hübner 2013; Bertoni et al. 2013; Devigne et al. 2013; Croce et al. 2013; Luukkonen et al. 2013; Bertoni and Tykvová 2015) have focused more on value creation by different types of VC investors than on their investment…”
- Government, Venture Capital and the Growth of European High-Tech Entrepreneurial Firms (2014, background): “An empirical comparison of the level and composition of value-added activities that are performed by GVCs and IVCs, as perceived by portfolio firms, is provided by Luukkonen et al. (2013).”
- Governmental venture capital in Europe: Screening and certification (2016, background): “The literature has shown that GVC investors provide limited value-enhancing services to the companies in their portfolios (Luukkonen et al. 2013) and consequently have a negligible treatment effect on company performance (Grilli and Murtinu 2014; Cumming et al. 2014; Bertoni and Tykvovà 2015;…”
- Does governmental venture capital spur invention and innovation? Evidence from young European biotech companies (2015, background): “While the contribution provided by IVCs tends to be more strategic and technological, GVCs may signal firm’s quality to stakeholders and attract additional financing (Lerner, 1999; Luukkonen et al., 2013).”
- Governmental venture capital for innovative young firms (2014, unknown): “Using a composite indicator of the value-adding activities of VCs in the seven European countries covered by the VICO project, Luukkonen et al. (2013) report that the profiles of value added differ across VC types.”